Forma Therapeutics (Now Novo Nordisk)
Developing novel therapeutics for patients
- B2B
About Forma Therapeutics (Now Novo Nordisk)
A clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare hematologic diseases and cancers, aiming to transform patients' lives
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- watertown, massachusetts, United States
- Founded
- 2007
- Revenue
- $19.7M – $156MTamtam estimate
- Website
- novonordisk.com
Forma Therapeutics (Now Novo Nordisk) at a glance
Forma Therapeutics (Now Novo Nordisk) is a B2B company in the Biotechnology Research industry, headquartered in watertown, massachusetts, United States.
Forma Therapeutics (Now Novo Nordisk) was founded in 2007.
Forma Therapeutics (Now Novo Nordisk) has 51–250 employees.
Forma Therapeutics (Now Novo Nordisk)'s revenue is $19.7M – $156M (Tamtam estimate).
Frequently asked questions about Forma Therapeutics (Now Novo Nordisk)
What is Forma Therapeutics (Now Novo Nordisk)'s revenue?
Tamtam estimates Forma Therapeutics (Now Novo Nordisk)'s annual revenue at $19.7M – $156M.
How many employees does Forma Therapeutics (Now Novo Nordisk) have?
Forma Therapeutics (Now Novo Nordisk) has 51–250 employees.
Where is Forma Therapeutics (Now Novo Nordisk) headquartered?
Forma Therapeutics (Now Novo Nordisk) is headquartered in watertown, massachusetts, United States.
Selling to companies like Forma Therapeutics (Now Novo Nordisk)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies